My-Grow

My-Grow is a French biotechnology company specializing in regenerative medicine for the treatment of hair loss and alopecia. The company is developing a breakthrough autologous cell therapy platform that aims to regenerate functional hair follicles using a patient's own cells. By leveraging advanced cell culture and tissue engineering techniques, My-Grow seeks to provide a permanent and natural solution for androgenetic alopecia and other forms of hair thinning. The company's approach focuses on restoring the natural hair growth cycle by reactivating and multiplying hair follicle stem cells. My-Grow is currently advancing its lead programs through pre-clinical development with the goal of entering clinical trials to address a significant unmet need in the global hair restoration market.